ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
Cuprum29
|
1.4K |
573K |
6 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
1.4K
|
573K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
Cuprum29
|
1.4K |
573K |
4 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
1.4K
|
573K
|
4
|
|
ASX - By Stock
|
FFG |
Re:
General Thoughts
|
|
Cuprum29
|
61 |
29K |
3 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
61
|
29K
|
3
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
Cuprum29
|
1.4K |
378K |
4 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
1.4K
|
378K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Cuprum29
|
73 |
17K |
2 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
73
|
17K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Cuprum29
|
73 |
17K |
2 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
73
|
17K
|
2
|
|
ASX - By Stock
|
TRP |
Re:
Ann: Company Update - Presentation
|
|
Cuprum29
|
17 |
4.1K |
2 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
17
|
4.1K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Cuprum29
|
73 |
17K |
1 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
73
|
17K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Cuprum29
|
73 |
17K |
4 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
73
|
17K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Cuprum29
|
73 |
17K |
4 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
73
|
17K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Cuprum29
|
73 |
17K |
3 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
73
|
17K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Cuprum29
|
12 |
3.6K |
6 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
12
|
3.6K
|
6
|
|
ASX - By Stock
|
TRP |
Re:
Ann: Company Update - Presentation
|
|
Cuprum29
|
17 |
4.1K |
0 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
17
|
4.1K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Cuprum29
|
72 |
21K |
4 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
72
|
21K
|
4
|
|
ASX - By Stock
|
TRP |
Re:
Tissue Repair: Hidden Gem in Biotech!
|
|
Cuprum29
|
175 |
43K |
2 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
175
|
43K
|
2
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Invion secures funding through an institutional placement
|
|
Cuprum29
|
12 |
8.0K |
3 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
12
|
8.0K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
Cuprum29
|
36 |
8.0K |
5 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
36
|
8.0K
|
5
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
Cuprum29
|
36 |
8.0K |
11 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
36
|
8.0K
|
11
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Trading Halt
|
|
Cuprum29
|
34 |
8.0K |
3 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
34
|
8.0K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Cuprum29
|
10K |
4.1M |
4 |
27/07/24 |
27/07/24 |
ASX - By Stock
|
10K
|
4.1M
|
4
|
|
ASX - By Stock
|
PER |
Re:
CMO interview not to be missed
|
|
Cuprum29
|
58 |
17K |
2 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
58
|
17K
|
2
|
|
ASX - By Stock
|
TRP |
Re:
Tissue Repair: Hidden Gem in Biotech!
|
|
Cuprum29
|
175 |
43K |
0 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
175
|
43K
|
0
|
|
ASX - By Stock
|
TRP |
Re:
Tissue Repair: Hidden Gem in Biotech!
|
|
Cuprum29
|
175 |
43K |
1 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
175
|
43K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
|
|
Cuprum29
|
169 |
49K |
4 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
169
|
49K
|
4
|
|
ASX - By Stock
|
TRP |
Re:
Tissue Repair: Hidden Gem in Biotech!
|
|
Cuprum29
|
175 |
43K |
3 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
175
|
43K
|
3
|
|
ASX - By Stock
|
NOV |
Re:
Ann: Sale of Interest in International Bank of Australia
|
|
Cuprum29
|
33 |
9.7K |
3 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
33
|
9.7K
|
3
|
|
ASX - By Stock
|
NOV |
Re:
Ann: Sale of Interest in International Bank of Australia
|
|
Cuprum29
|
33 |
9.7K |
3 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
33
|
9.7K
|
3
|
|
ASX - By Stock
|
TRP |
Re:
Tissue Repair: Hidden Gem in Biotech!
|
|
Cuprum29
|
175 |
43K |
2 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
175
|
43K
|
2
|
|
ASX - By Stock
|
NOV |
Re:
Ann: Sale of Interest in International Bank of Australia
|
|
Cuprum29
|
33 |
9.7K |
9 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
33
|
9.7K
|
9
|
|
ASX - By Stock
|
PER |
Re:
CMO interview not to be missed
|
|
Cuprum29
|
58 |
17K |
6 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
58
|
17K
|
6
|
|
ASX - By Stock
|
TRP |
Re:
Tissue Repair: Hidden Gem in Biotech!
|
|
Cuprum29
|
175 |
43K |
3 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
175
|
43K
|
3
|
|
ASX - By Stock
|
NOV |
Re:
Ann: Sale of Interest in International Bank of Australia
|
|
Cuprum29
|
33 |
9.7K |
1 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
33
|
9.7K
|
1
|
|
ASX - By Stock
|
PER |
Re:
CMO interview not to be missed
|
|
Cuprum29
|
58 |
17K |
9 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
58
|
17K
|
9
|
|
ASX - By Stock
|
PER |
Re:
CMO interview not to be missed
|
|
Cuprum29
|
58 |
17K |
20 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
58
|
17K
|
20
|
|
ASX - By Stock
|
TRP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Cuprum29
|
47 |
8.3K |
0 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
47
|
8.3K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
Cuprum29
|
107 |
37K |
17 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
107
|
37K
|
17
|
|
ASX - By Stock
|
NOV |
Re:
Ann: Trading halt
|
|
Cuprum29
|
20 |
7.2K |
3 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
20
|
7.2K
|
3
|
|
ASX - By Stock
|
TRP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Cuprum29
|
47 |
8.3K |
0 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
47
|
8.3K
|
0
|
|
ASX - By Stock
|
TRP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Cuprum29
|
47 |
8.3K |
0 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
47
|
8.3K
|
0
|
|
ASX - By Stock
|
FFG |
Re:
General Thoughts
|
|
Cuprum29
|
61 |
29K |
1 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
61
|
29K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
Cuprum29
|
238 |
70K |
1 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
238
|
70K
|
1
|
|
ASX - By Stock
|
IMR |
Re:
Ann: Imricor Successfully Raises A$35 Million via Placement
|
|
Cuprum29
|
4 |
2.1K |
3 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
4
|
2.1K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial
|
|
Cuprum29
|
36 |
10K |
1 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
36
|
10K
|
1
|
|
ASX - By Stock
|
AYA |
Re:
News: AYA Artrya Announces Five Year Strategic Agreement With Cone Health
|
|
Cuprum29
|
4 |
2.5K |
1 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
4
|
2.5K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
Cuprum29
|
238 |
70K |
1 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
238
|
70K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
Cuprum29
|
238 |
70K |
11 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
238
|
70K
|
11
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL to Present at Bioshares Biotech Summit - Presentation
|
|
Cuprum29
|
67 |
14K |
1 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
67
|
14K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
|
|
Cuprum29
|
169 |
49K |
3 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
169
|
49K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
|
|
Cuprum29
|
169 |
49K |
1 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
169
|
49K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
|
|
Cuprum29
|
169 |
49K |
3 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
169
|
49K
|
3
|
|